MTD Mettler-Toledo International Inc.
Healthcare$1103.09+1.16%ClosedMarket Cap: $22.29B
As of 2026-05-25
Valuation
P/E (TTM)
29.70
PEG
42.35
P/B
-534.28
P/S
5.45
EV/EBITDA
19.74
DCF Value
$642.61
FCF Yield
3.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.8%
Operating Margin
28.0%
Net Margin
21.4%
ROE
-610.3%
ROA
23.9%
ROIC
36.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $947.1M | 58.7% | $246.2M | $169.5M | $— | — |
| Q4 null | $1.13B | 58.0% | $343.3M | $285.8M | $— | — |
| FY null | $4.03B | 57.5% | $1.12B | $869.2M | $— | — |
| Q3 null | $1.03B | 57.2% | $289.9M | $217.5M | $— | — |
| Q2 null | $983.2M | 57.2% | $265.7M | $202.3M | $— | — |
| Q1 null | $883.7M | 57.6% | $219.5M | $163.6M | $— | — |
| Q4 null | $1.05B | 59.4% | $333.7M | $252.3M | $— | — |
| FY null | $3.87B | 58.2% | $1.13B | $863.1M | $— | — |
| Q3 null | $954.5M | 58.1% | $278.3M | $211.5M | $— | — |
| Q2 null | $946.8M | 57.8% | $265.9M | $221.8M | $— | — |
| Q1 null | $925.9M | 57.2% | $249.1M | $177.5M | $— | — |
| Q4 2023 | $935.0M | 57.1% | $263.7M | $184.8M | $8.52 | — |